Literature DB >> 4746561

Renal pathologic lesions and functional alterations in a man with Fabry's disease.

R C Pabico, B C Atancio, B A McKenna, T Pamukcoglu, R Yodaiken.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4746561     DOI： 10.1016/0002-9343(73)90140-x

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  8 in total

1.  Fabry's disease discovered with chance urinary mulberry cells: a case report.

Authors:  Takashi Nakamichi; Mariko Miyazaki; Keisuke Nakayama; Mitsuhiro Sato; Naoki Akiu; Toshinobu Sato; Hiroshi Sato; Sadayoshi Ito
Journal:  CEN Case Rep       Date:  2012-10-31

2.  Generalized gangliosidosis type II (juvenile GM1 gangliosidosis). A pathological, histochemical and ultrastructural study.

Authors:  E F Gilbert; J Varakis; J M Opitz; G M ZuRhein; R Ware; C Viseskul; E G Kaveggia; H A Hartmann
Journal:  Z Kinderheilkd       Date:  1975-09-11

3.  [Fabry's disease, glomerulonephritis with crescentic and granulomatous interstitial nephritis. Case of one family].

Authors:  J Kriegsmann; M Otto; E Wandel; A Schwarting; J Faust; T Hansen; J Beck; C Whybra; M Beck
Journal:  Pathologe       Date:  2003-10       Impact factor: 1.011

Review 4.  Lysosomal storage diseases.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-05-25

5.  Abnormal expression and processing of uromodulin in Fabry disease reflects tubular cell storage alteration and is reversible by enzyme replacement therapy.

Authors:  P Vylet'al; H Hůlková; M Zivná; L Berná; P Novák; M Elleder; S Kmoch
Journal:  J Inherit Metab Dis       Date:  2008-07-27       Impact factor: 4.982

Review 6.  Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel.

Authors:  Alessandro P Burlina; Katherine B Sims; Juan M Politei; Gary J Bennett; Ralf Baron; Claudia Sommer; Anette Torvin Møller; Max J Hilz
Journal:  BMC Neurol       Date:  2011-05-27       Impact factor: 2.474

7.  Pharmacological chaperone therapy for Fabry disease.

Authors:  Satoshi Ishii
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

8.  Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy.

Authors:  Woo-Shik Kim; Hyun Soo Kim; Jinho Shin; Jong Chun Park; Han-Wook Yoo; Toshihiro Takenaka; Chuwa Tei
Journal:  J Korean Med Sci       Date:  2019-02-15       Impact factor: 2.153
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.